Skip to main content
Clinical Trials/JPRN-UMIN000010568
JPRN-UMIN000010568
Completed
Phase 2

Randomised clinical trial to evaluate postoperative quality of life and body weight loss with the use of EPA-enriched nutrient for resectable gastric cancer patients - Postoperative QOL and body weight loss with perioperative Prosure administration for gastric cancer patients

Jichi Medical University Hospital0 sites160 target enrollmentApril 23, 2013
Conditionsgastric cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
gastric cancer
Sponsor
Jichi Medical University Hospital
Enrollment
160
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 23, 2013
End Date
December 31, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. reduced oral intake 2\. Treated with icosapentate ethyl 3\. supplements containing eicosapentaenoic acid 4\. synchronous or metachronous cancer 5\. lactate intolerance or allergic reaction to milk/soy 6\. hemorrhagic tendency 7\. uncontrolled diabetes mellitus 8\. Systemic treatment with corticosteroids 9\. unstable angina or cardiac infarction within 6 months 10\. pulmonary disease under oxygenation 11\. Woman with ongoing pregnancy or breast\-feeding, or contemplating pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials